Skip to main content
GutCited

विवरण

Additional outcome data from the placebo-controlled clinical trial evaluating fructooligosaccharide supplementation for constipation in infants. The study assessed multiple gastrointestinal endpoints over the treatment period.

Cite This Figure

![Figure 6: Additional outcome data from the placebo-controlled clinical trial evaluating fructooligosaccharide supplementation for constipation in infants. The study assessed multiple gastrointestinal endpoints over the treatment period.]()

> Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." *Nutrients*, 2018. PMID: [30388751](https://pubmed.ncbi.nlm.nih.gov/30388751/)
<figure>
  <img src="" alt="Additional outcome data from the placebo-controlled clinical trial evaluating fructooligosaccharide supplementation for constipation in infants. The study assessed multiple gastrointestinal endpoints over the treatment period." />
  <figcaption>Figure 6. Additional outcome data from the placebo-controlled clinical trial evaluating fructooligosaccharide supplementation for constipation in infants. The study assessed multiple gastrointestinal endpoints over the treatment period.<br>  Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30388751/">30388751</a></figcaption>
</figure>